Boardroom Alpha
Meeting calendar
ELV · Annual meeting · Wednesday, May 13, 2026

Elevance Health Inc

3 nominees · 4 ballot items.

Election of three directors; advisory approval of named executive officer compensation (Say-on-Pay); ratification of Ernst & Young LLP as independent auditors; shareholder proposal requesting an independent study on prohibiting corporate contributions to partisan 527 tax-exempt political groups.

Market cap
$80.9B
1Y TSR
+29.0%
Board grade
B-
Record date
Mar 13, 2026
Filing
DEF 14A
Meeting concluded · May 13, 2026

Follow how the vote landed and what changed on Elevance Health Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot4

  1. 1

    Election of Three Directors

    ManagementBoard: FOR

    Elect three director nominees (Gail K. Boudreaux, Robert L. Dixon, Jr., Deanna D. Strable) to serve three-year terms expiring at the 2029 Annual Meeting.

  2. 2

    Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay

    ManagementBoard: FOR

    Non-binding advisory vote to approve the compensation of the company's Named Executive Officers as disclosed in the proxy statement.

  3. 3

    Ratification of Ernst & Young LLP as Auditors for 2026

    ManagementBoard: FOR

    Ratify the appointment of Ernst & Young LLP as Elevance Health’s independent registered public accounting firm for the year ending December 31, 2026.

  4. 4

    Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups

    Shareholder — Trillium ESG Global Equity FundBoard: AGAINST

    Shareholder proposal requesting the Board commission and publish an independent study examining the impact of adopting a policy prohibiting corporate funds for direct contributions to partisan 527 tax-exempt political groups.

Director elections

Nominees on the ballot3

Not independent
Tenure on this board
9.5 yrs
Also a director at
Target Corp (TGT)
Independent
Tenure on this board
3.7 yrs
Also a director at
Principal Financial Group Inc (PFG)
Ownership

Top institutional holders10

Latest 13F quarter
1DAVENPORT Co LLC0.2%441,940$171M
2Swedbank AB0.1%302,501$117M
3Assenagon Asset Management S.A.0.1%299,374$116M
4Maj Invest Holding A/S0.1%229,987$89M
5Curated Wealth Partners LLC0.1%182,066$742K
6PROFESSIONAL ADVISORY SERVICES INC0.0%68,657$27M
7ROCKLAND TRUST CO0.0%68,467$26M
8Czech National Bank0.0%61,813$24M
9PensionDanmark Pensionsforsikringsaktieselskab0.0%57,429$22M
10Y-Intercept (Hong Kong) Ltd0.0%49,698$19M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Elevance Health Inc 2026 annual meeting?
Elevance Health Inc (ELV) holds its 2026 annual shareholder meeting on Wednesday, May 13, 2026.
What is the record date for the Elevance Health Inc 2026 meeting?
The record date for the Elevance Health Inc 2026 meeting is Friday, March 13, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Elevance Health Inc's 2026 meeting?
The board is presenting 3 director nominees at the Elevance Health Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Elevance Health Inc 2026 meeting?
Shareholders will vote on 4 proposals at the Elevance Health Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer